BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 30, 2009
View Archived Issues
AVI BioPharma reports efficacy data from phase Ib/II clinical trial of AVI-4658 in DMD
Read More
Forest Laboratories to acquire additional rights to NXL-104 under agreement with Novexel
Read More
Novel DNA-binding compounds presented by CSIR
Read More
GlaxoSmithKline describes nAChR modulators as antipsychotic agents
Read More
Mitsubishi Tanabe Pharma discloses novel BK and maxi K+ channel openers
Read More
Cathepsin C inhibitors for the treatment of COPD identified by GlaxoSmithKline
Read More
Lilly identifies CB1 ligands for the treatment of obesity
Read More
New data indicate ridaforolimus-trastuzumab beneficial in refractory metastatic breast cancer
Read More
Compugen discovers drug target for treatment of epithelial tumors
Read More
Sinovac Biotech files application with SFDA for clinical trial of HFMD vaccine
Read More
SemBioSys Genetics presents update of its progress on Apo AI(Milano)
Read More
Tego Biosciences sells intellectual property to Luna Innovations
Read More
BTC induces apoptosis in PKCalpha overexpressing breast cancer cells
Read More
Glycemic control enhanced by adding alogliptin to insulin therapy in type 2 diabetes
Read More
Breast cancer growth inhibition seen with JMR-132 and tamoxifen
Read More
MVA-BN-HER2 well tolerated, active in phase I breast cancer studies
Read More
Tetrathiomolybdate may reduce endothelial progenitor cells in breast cancer patients
Read More
EMEA issues negative opinion on Cerepro for malignant brain cancer
Read More
Affomix to provide antibodies for Kalgene's diagnostics program
Read More
LifeCycle submits phase III protocol for LCP-Tacro trial to the FDA
Read More
Vical's phase III trial of Allovectin-7 receives positive safety review
Read More
Vivus submits NDA for Qnexa to FDA for treatment of obesity
Read More
Arigene terminates tender offer for Trimeris' outstanding shares of common stock
Read More
GSK identifies 5-HT2B receptor antagonists for fibrotic conditions and IBS
Read More
Gilead describes SCD inhibitors for the treatment of obesity
Read More